Statistic-Non Cancer Disease
Results of clinical trials
Treatment of non-oncological diseases using GA-40
The Region of Eastern Europe (2009-20013)
GA-40 Treatment of Non-Oncological Diseases
Clinical studies have shown that the GA-40 can be recommended for the treatment of the following diseases: immunodeficiency, viral infections - viral hepatitis (B, C, D, B +, F ..), non-viral hepatitis - cirrhosis, herpes virus, human papilloma virus, papilloma’s, warts , polyps, cysts, trichomoniasis, meningitis, gout, scleroderma, leukoplakia, leukopenia, erythropenia, thrombocytopenia, post-infarction, post-stroke and post-operative rehabilitation, tuberculosis, prostatitis, glomerulonephritis, chronic cholecystitis, prevention of micro and macrovascular, chronic inflammatory diseases, allergy, asthma , gastrointestinal disease, autoimmune disease, diabetes, chronic gastritis, neurasthenia, chronic lung infections, diarrhea, poor coronary blood flow, cerebral arteriosclerosis, endocrine disorders, menstrual imbalances, menstrual disorders, impotence, immunological infertility, weakness of the body, myasthenia gravis, early aging (rejuvenation and life extension).
Immunotherapeutic and anti-carcinogenic drug GA-40 has been used for 15 years, and not only in our country but also in many countries of the world. Today we can say with confidence that our innovative treatment drugs gives hope for a healthy and long life.
We hope that you will discover how effective the GA-40 to restore and enhance the immune system as effective for the prevention, prevention and the fight against cancer and other serious diseases.